PYPD — PolyPid Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1611842 ·
Last close
$4.66
Market Cap
$89.45M
52W High
$5.21
52W Low
$4.03
ADV30
127,347
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,760,000 | -7,728,000 | 19,160,000 | 8,888,000 | 10,380,000 |
| Dec 2025 | 0 | — | -8,530,000 | -8,473,000 | 22,307,000 | 6,402,000 | 11,334,000 |
| Sep 2025 | 0 | — | -7,455,000 | -7,451,000 | 26,841,000 | 9,669,000 | 11,476,000 |
| Jun 2025 | 0 | — | -9,403,000 | -9,977,000 | 37,687,000 | 17,448,000 | 17,211,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-301,500,000
Inventory
$1,106,000
Receivables
—
ST Investments
$6,531,000
EBIT TTM
$-33,290,000
Pretax Income TTM
$-34,164,000
Interest Exp TTM
$1,839,000
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -32,967,000 | -34,169,000 | 22,307,000 | 11,334,000 | — | -27,879,000 |
| Dec 2024 | 0 | -28,029,000 | -29,022,000 | 25,220,000 | 17,536,000 | — | -21,963,000 |
| Dec 2023 | 0 | -22,867,000 | -23,865,000 | 15,372,000 | 17,468,000 | — | -17,236,000 |
| Dec 2022 | 0 | -38,888,000 | -39,557,000 | 25,971,000 | 20,142,000 | — | -34,317,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.25
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.70 · call volume: 7 · put volume: 100
Expected Move to 2026-11-20:
±$3.92
(83.60%) —
implied range
$0.77 –
$8.62
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STIM | Neuronetics, Inc. | $88.38M | $1.27 | — |
| SKIN | SkinHealth Systems Inc. | $84.93M | $0.66 | — |
| EBRCZ | EBR Systems, Inc. | $84.30M | $0.19 | — |
| NRXS | Neuraxis, INC | $84.21M | $6.80 | — |
| VANI | Vivani Medical, Inc. | $97.45M | $1.13 | — |
News headlines (Yahoo Finance, 1h cache)
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
2026-06-01 12:30 · Yahoo
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
2026-05-20 12:30 · Yahoo
PolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
2026-05-13 23:01 · Yahoo
PolyPid Ltd. Q1 2026 Earnings Call Summary
2026-05-13 20:58 · Yahoo
PolyPid (PYPD) Q1 2026 Earnings Transcript
2026-05-13 19:01 · Yahoo
PolyPid Q1 Earnings Call Highlights
2026-05-13 18:09 · Yahoo
PolyPid Q1 2026 Earnings Call: Complete Transcript
2026-05-13 13:24 · Yahoo
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
2026-05-13 11:30 · Yahoo
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
2026-05-06 12:00 · Yahoo
PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting
2026-04-28 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.